Wheeze attacks during the first 3 years of life following an episode of hospitalized bronchiolitis – is there a viral association? Source: International Congress 2019 – Aetiology and management of childhood respiratory infections, primary ciliary dyskinesia and asthma Year: 2019
To establish the characteristics which influence patients with an acute exacerbation of COPD to die within 2 weeks of hospital admission compared to those after a 2-week period Source: Eur Respir J 2005; 26: Suppl. 49, 283s Year: 2005
Clinical background in young adult patients hospitalized with severe asthma exacerbation –Comparison of the present with 10 years ago– Source: Annual Congress 2010 - Clinical aspects of asthma and allergic respiratory diseases Year: 2010
A ten year follow-up of former paediatric asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 233s Year: 2005
Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study Source: Annual Congress 2011 - COPD management Year: 2011
The rates of admission for asthma patients in the last ten years Source: Eur Respir J 2002; 20: Suppl. 38, 317s Year: 2002
COPD exacerbation phenotypes in a five year hospitalisation cohort Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018
Omalizumab in severe uncontrolled asthma: two and a half year clinical experience Source: Annual Congress 2009 - Towards improving asthma control Year: 2009
"It‘s like living with a time bomb"– European patients‘ perspective on severe asthma symptoms Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005
Does lung function change in the months after an asthma exacerbation in children? Source: Virtual Congress 2021 – Paediatric asthma and bronchopulmonary dysplasia Year: 2021
‘Real-life‘ persistence beyond the first year of omalizumab treatment in patients with severe allergic asthma: The R-Pixel study Source: Annual Congress 2011 - Asthma management and response Year: 2011
Are patients who overuse short acting β2-agonists more likely to report high levels of asthma symptoms? Source: Eur Respir J 2003; 22: Suppl. 45, 410s Year: 2003
Regular follow-up visits reduce the risk for severe asthma exacerbation required admission Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017
Should the number of acute exacerbations in the previous year be used to guide treatments in COPD? Source: Eur Respir J, 57 (2) 2002122; 10.1183/13993003.02122-2020 Year: 2021
Reslizumab for uncontrolled eosinophilic asthma in patients who experienced a single exacerbation in the previous year: sub-analysis of two phase 3 trials Source: International Congress 2017 – Asthma management Year: 2017
Impact of risk factors on the requirement of long term preventers at 3 years following first admission for wheezing in the initial 2 years of life Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations Year: 2018
Episodic home interventions in bedridden chronic respiratory failure patients: a 3 year survey Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care Year: 2008
Evaluation of day and night symptoms in patients with asthma Source: Eur Respir J 2001; 18: Suppl. 33, 208s Year: 2001
Late Breaking Abstract - Danirixin (GSK1325756) improves respiratory symptoms and health status in mild to moderate COPD – results of a 1 year first time in patient study Source: International Congress 2017 – Primary care management of respiratory symptoms, allergies, inhalers and adherence Year: 2017
Infants at high-risk of asthma have in the first 6 months of life more asthma like complaints than low-risk infants Source: Eur Respir J 2003; 22: Suppl. 45, 355s Year: 2003